Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

NOVEMBER 12, 2021

THE Chairman of a recently-listed UK pharmaceutically-focused cannabis company has stood down after a breach of market rules. The Group is developing drug candidates through clinical trials to gain regulatory approval (FDA/MHRA/EMA) that will enable medical professionals to prescribe them with confidence. Business Cann Report.

Cannabinoids 98

Cannabinoids Clinical Trials Research and Development Pharmaceutical 98

Veriheal

MARCH 23, 2023

Japan’s latest Cannabis Control Law revisions would apply to pharmaceutical-grade medicinal cannabis products. The report states that the revision is an essential move for ensuring the legal use of cannabis-derived epilepsy drug Epidiolex , which is currently being reviewed as part of a series of clinical trials in Japan.

Legalization 81

Legalization Marijuana Clinical Trials Seed-To-Sale 81

Cannabis Law Report

FEBRUARY 10, 2022

The report includes: A deep dive into psychedelic drug policy reform efforts and successes in 2021, with a focus on key jurisdictions including the U.S. A look at key research and clinical trials that were published in 2021, with analysis of themes like microdosing and SSRI interactions. and Canada.

Clinical Trials 52

Clinical Trials Microdosing Pharmaceutical Policy 52

Cannabis Law Report

OCTOBER 10, 2021

As a senior manager at Cantourage and with us as a team you can develop and shape the pharmaceuticals market in Europe. Provide guidance on clinical trials and plays integral role in bringing new product innovations to different markets in Europe (and beyond). pharmacology, toxicology, chemistry). Advanced degree preferred.

Clinical Trials 52

Clinical Trials Medicine Therapy Pharmaceutical 52

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? It was also unique because it used whole-plant cannabis, rather than single-molecule extracts or synthetic pharmaceutical cannabinoids. .

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

Cannabis Law Report

APRIL 21, 2022

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine and profiled on the front page of The New York Times. The State Government Affairs Lead will oversee MAPS PBC’s policy efforts at the state level. Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Treatment 52

Cannabis Law Report

NOVEMBER 19, 2021

It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. Prior experience as a regional regulatory lead, ideally US and/or UK/EU in pharmaceutical industry. Key Responsibilities.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

Cannabis Law Report

AUGUST 7, 2022

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. Psychedelic Alpha Policy Map.

Law 74

Law Research and Development Therapy Treatment 74

Cannabis Info

OCTOBER 11, 2019

In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. The spray will be produced by MGC Pharmaceuticals, an Australian firm founded by Israeli researchers. The clinical trial will be held over a 14-month period starting early next year.

Treatment 45

Treatment Clinical Trials Cannabinoids Cannabis 45

Cannabis Law Report

JULY 13, 2019

clinical trials have been made by Members of Parliament. After months of interviews and weighing-up reams of evidence The House of Commons Health and Social Care Committee has issued its latest report; ‘ Drugs policy: medicinal cannabis’. CBD Testers.co

Research and Development 40

Research and Development Clinical Trials Epilepsy Medicine 40

Cannabis Law Report

NOVEMBER 15, 2021

References: Statement from then FDA Commissioner Scott Gottlieb, MD, and Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies. News release. FDA website. January 15, 2019. 2021 Aug 26;23:119-127. doi: 10.1016/j.omtm.2021.08.006.

Research and Development 40

Research and Development Therapy Clinical Trials Supply Chain 40

Cannabis Law Report

JUNE 1, 2021

Steve Barbera is an accomplished cross-functional leader in the healthcare industry, with over 20 years of experience in the development and implementation of complex market access strategies including health policy, pricing and reimbursement, contracts and coding.

Research and Development 51

Research and Development Treatment Pharmaceutical Patients 51

The Cannigma

JUNE 15, 2021

Sonya Yruel/Drug Policy Alliance). A recent review of scientific literature 10 on the pharmacology and therapeutic targets of CBD, looked at the state of clinical research on CBD in a variety of conditions and may give us a better understanding of its potential benefits. . How to dose CBD.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

DECEMBER 20, 2021

The three states that presently have a policy on hemp cultivation are Uttarakhand, Uttar Pradesh, and Madhya Pradesh. The clinical trials shall be conducted to comply with Rule 158(B) of the Drugs and Cosmetics Rules.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

Cannabis Law Report

JULY 15, 2019

ACM takes in consideration the characteristics of medical cannabis preparations and substances, and is a simplified version of the marketing authorization required for medicinal products to some extent (for instance, no clinical trials are required). Author: João Taborda da Gama. 351 914 725 808. joao.gama@gamagloria.com.

Medicine 40

Medicine Clinical Trials Patients Access 40

MMJ Recs

AUGUST 1, 2024

The appeal of medical marijuana lies in its natural origin and holistic approach, offering an alternative to traditional pharmaceuticals with fewer side effects. Some areas permit medical marijuana with a physician’s recommendation, while others have more restrictive policies.

Patients 52

Patients Chronic Pain Marijuana Sleep 52

SpeedWeed

DECEMBER 28, 2018

Marinol (synthetic THC) has been available by prescription since 1986, and other synthetic cannabinoid drugs are in the works, but Epidiolex is the first plant-derived pharmaceutical to reach the US market. As captured in the store’s surveillance video, the four cowardly criminals were clearly no match for a good guy with a bong.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

Cannabis Law Report

JULY 15, 2022

The schedule eight pharmaceutical medicine has gained federal approval to treat conditions including cancer-related pain, nausea and vomiting, multiple sclerosis and epilepsy, and for use in palliative care. We are at the crossroads of good agriculture meets good health care which meets great policy. ABC Rural: Jennifer Nichols ).

Medicine 52

Medicine Patients Media Supply Chain 52

Cannabis Law Report

NOVEMBER 24, 2021

These publications offer valuable indicators for current debates and disputes, political contestations, demands for reform or policy change, reactions to research activities and evidence, as well as attitudes from the medical profession towards new treatments and therapies like medicinal cannabis. 11) rather than a plant product ( n ?=?4).

Research and Development 52

Research and Development Medicine Access Media 52

Veriheal

JANUARY 5, 2023

These effects were not majorly modulated by CBD, regardless of the dosage—a discovery that the study authors say should be considered in future health policy and safety decisions. The post Clinical Trial Explores CBD’s Influence on Cannabis Safety appeared first on Cannabis Central. Gaia Herbs Hemp, and Joy Organics.

Clinical Trials 97

Clinical Trials Safety Consumption CBD 97

Canna Law Blog

OCTOBER 5, 2022

However, if this recommendation is actually taken up by the government, legitimate medical marijuana products may be imported into Japan under its existing laws for pharmaceuticals and medical devices. We could see medical marijuana in Japan in the near future, which would be huge for Asian cannabis policy and the world.

Marijuana 98

Marijuana Seed-To-Sale Clinical Trials Epilepsy 98

The Cannigma

JUNE 14, 2021

‘Junk’ cannabis ‘ill-suited for clinical trials’. The cannabis grown at the University of Mississippi “is junk, ill-suited for clinical trials, and genetically closer to hemp than the marijuana available from dispensaries and used by Americans nationwide,” according to the lawsuit. Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Canna Law Blog

MAY 7, 2020

for various studies, including FDA-approved clinical trials. Specifically, in August 2016, the DEA published in the Federal Register a policy statement “ designed to increase the number of entities registered under the [CSA] to grow (manufacture) marijuana to supply legitimate researchers in the United States.”

DEA 98

DEA Research and Development Cultivation Supply Chain 98

CannaMD

MARCH 8, 2021

Journal of Economic Analysis & Policy , and Journal of Drug Issues all report drops in crime following marijuana legalization. Then in 1975, the FTC sued the AMA, claiming the organization’s anti-marketing policy constituted unreasonable “restraint of trade.”. In 2016, the pharmaceutical industry spent $9.6

THC 116

THC Research and Development Treatment Patients 116

Cannabis Law Report

APRIL 10, 2019

MP Philippa Whitford (representing Central Ayrshire ), a doctor, called for more support for clinical trials so that doctors will be more willing to prescribe medical cannabis products: “That is quite scary for doctors, particularly as if it is an unlicensed drug, they have to sign a form to say that they accept personal liability.

Clinical Trials 51

Clinical Trials Epilepsy Medicine Research and Development 51

Weedistry

FEBRUARY 4, 2019

One of the most common arguments against the efficacy of medical cannabis today is that public policy is outpacing real science. First, plenty of pharmaceutical drugs, that we broadly accept as legitimate medicine, received approval from the U.S. For comparison, about a third of pharmaceutical medicines on the U.S.

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

Cannabis Law Report

JUNE 3, 2022

Provide legal advice for a wide range of clinical, licensing and regulatory matters. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Experience drafting corporate agreements and policies.

Legalization 59

Legalization Clinical Trials Compliance Compliance 59

The Cannigma

MAY 7, 2021

In Europe, Murphy explains, cannabis products are held to the same standards of accountability and repeatability as other pharmaceuticals. What do those more pharmaceutical standards mean for patients? MSO: Obviously, every country is different but within Europe and certain rainy islands close to it. SM: I think it’s stability.

Supply Chain 126

Supply Chain Patients Access Hemp 126

Cannabis Law Report

FEBRUARY 15, 2019

The Singapore Online Citizen reports… Law & Home Affairs Minister K Shanmugam says that pharmaceutical companies are hiding their intentions behind a smokescreen when it comes to cannabis. These can be administered through pharmaceutical products such as oral solutions and sprays.

Medicine 45

Medicine Pharmaceutical Law Cannabinoids 45

Cannabis Law Report

MARCH 1, 2022

Provide legal advice for a wide range of clinical, licensing and regulatory matters. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Experience drafting corporate agreements and policies.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

Cannabis Law Report

OCTOBER 2, 2021

Provide legal advice for a wide range of clinical, licensing and regulatory matters. Develop, implement, and maintain written policies, procedures, and guidelines to facilitate compliance with federal, state, and local laws, regulations, and rules, and industry standards. Experience drafting corporate agreements and policies.

Legalization 52

Legalization Clinical Trials Compliance Compliance 52

SpeedWeed

MARCH 18, 2021

Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. for the production of cannabis used in federally-regulated clinical trials. Research quality” cannabis sparked earlier controversy.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. CB2 Insights recently published an infographic detailing the increased attention large multinational pharmaceutical companies are paying to the cannabis industry.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

DECEMBER 30, 2019

After this historically successful year, we expect to see public and political support continue to increase in 2020 as more and more states implement sensible cannabis regulatory policies. “Never before in American history has marijuana policy advanced in Congress as far or as fast in one year as 2019. Erik Altieri.

Legislation 45

Legislation Patients Access Banking 45

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. There’s the one drug, one target, cannabis is multiple active ingredients and acts on multiple targets in the body.

Legalization 132

Legalization Patients Education Dispensary 132

Cannabis Law Report

MARCH 29, 2022

Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. Prior to his work at Moderna, Mullette developed broad pharmaceutical expertise with Sanofi in a variety of management roles in the U.S., Mullette joins MAPS PBC after more than 20 years in the pharmaceutical industry. He holds a B.S.

Pharmaceutical 52

Pharmaceutical Therapy Clinical Trials Access 52